AbbVie Inc (BUE:ABBV)
ARS 20300 -2850 (-12.31%) Market Cap: 308.31 Tn Enterprise Value: 372.12 Tn PE Ratio: 60.57 PB Ratio: 51.09 GF Score: 68/100

Q1 2024 AbbVie Inc Earnings Call Transcript

Apr 26, 2024 / 01:00PM GMT
Release Date Price: ARS12411.5
Operator

Good morning, and thank you for standing by. Welcome to the AbbVie First Quarter 2024 Earnings Conference Call. (Operator Instructions) Today's call is also being recorded. If you have any objections, you may disconnect at this time.

I would now like to introduce Ms. Liz Shea, Senior Vice President of Investor Relations. Ma'am, you may begin.

Elizabeth Shea
AbbVie Inc. - SVP of IR

Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Rob Michael, President and Chief Operating Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Scott Reents, Executive Vice President, Chief Financial Officer; Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics; and Roopal Thakkar, Senior Vice President, Chief Medical Officer, Global Therapeutics. Joining us for the Q&A portion of the call is Tom Hudson, Senior Vice President, Chief Scientific Officer, Global Research.

Before we get started, I'll note that some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot